Babies, Blemishes and FDA: A History of Accutane Regulation in the United States
Author
Metadata
Show full item recordCitation
Babies, Blemishes and FDA: A History of Accutane Regulation in the United States (2002 Third Year Paper)Abstract
This paper takes a journalistic approach, tracing the chronology of Accutane in the U.S. in order to fill in the gaps of the story that has inspired so much controversy. Accutane has repeatedly pushed the frontier of FDA regulation, as the agency struggled to adapt its tools to meet the challenge of an extremely effective and extremely dangerous medication. By emphasizing the evolving American response to the high level of risk associated with Accutane, I hope to provide the material needed to evaluate the strengths and weaknesses of our current regulatory framework.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963867
Collections
- HLS Student Papers [498]
Contact administrator regarding this item (to report mistakes or request changes)